Strengthen skills, increase levels of knowledge and stay up-to-date on the latest research with just one visit to SSO’s online educational platform, ExpertED@SSO. Several new webinars for the month of May have been announced and registration is now open.
The Framework to Submitting a Successful Abstract | May 1, 2019 | 4 pm CT.
Moderated by: Danny M. Takanishi, Jr., MD and Yanghee Woo, MD with guest speaker Rebecca Auer, MD, MSC.
This webinar will help to increase knowledge of proficient scientific abstract formulation and the ability to practically apply this knowledge in the submission process for consideration by scientific symposia program committees.
You may find this activity in the Other Surgical Oncology section in the ExpertED@SSO catalog.
Should a Patient with a 2 cm HER2+/TNBC Clinically Node Negative Receive Neoadjuvant Therapy? |
May 9, 2019 | 2 pm CT
Faculty: Julie Margenthaler, MD and Sarah McLaughlin, MD
Based on the SSO 2019 Great Debate, this webinar will present data and compare and contrast the benefits and limitations of upfront surgery and neoadjuvant therapy for TNBC and discuss resectable HER2+.
You may find this activity in the Breast Disease section in the ExpertED@SSO catalog.
This activity is partially supported by an independent educational grant from Genentech.
Young Adult Onset Colorectal Cancer: What is going on? | May 15, 2019 | 3 pm CT
Faculty: J. Joshua Smith, MD, PhD, Y. Nancy You, MD, MHSc, and Heather Yeo, MD, MHS.
Young-onset colorectal cancer is distinct in many ways. Location of the tumor varies substantially with age and cancers are also histologically more aggressive. This webinar will review practice changing papers and national screening guidelines and age-related differences in colorectal cancer that have implications for diagnosis and treatment.
You may find this activity in the Colorectal Disease section in the ExpertED@SSO catalog.
Multi-Modality Management of Stage IV Melanoma in the Era of Immunotherapy |May 29, 2019 | 5 pm CT
Faculty: Omid Hamid, MD, Genevieve Boland, MD, PhD, Mark Faries, MD and Charlotte Ariyan, MD
Learn about the mechanisms of action and toxicities of novel immunotherapeutic agents for metastatic melanoma and how to best integrate these agents with surgical options. This case-based webinar will cover topics including systemic therapy, immune adjuvants for Stage IV melanoma, management of oligometastatic disease and surgical outcomes in melanoma in combination with immunotherapy.
You may find this activity in the Melanoma Disease section in the ExpertED@SSO catalog.
This activity is partially supported by independent educational grants from Amgen, Bristol Myers Squibb and Merck.